Aardvark Therapeutics, Inc. Common Stock

NASDAQ:AARD

Biotechnology

Healthcare
$3.95 +2.36%

+$0.09 today

Market cap
$86.45M
Beta
4.47
P/E (TTM)
-1.2
EPS (TTM)
-$3.20
52W Low $3.35High $17.94

Volume 1.32M

Average 0.18M

Balance Sheet

Inspect the capital base behind the business.

Assets

$117.18M

FY 2025 · Annual

+51.2% YoY

Liabilities

$10.55M

FY 2025 · Annual

-92.0% YoY

Equity

$106.63M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents15.56M9.74M61.64M47.05M
Short-term Investments546K254K12.02M62.98M
Net Receivables0000
Inventory0000
Other Current Assets70K127K160K1.86M
Total Current Assets16.49M10.37M74.14M111.89M
Property, Plant & Equipment (Net)252K155K735K355K
Goodwill0000
Intangible Assets0000
Long-term Investments0000
Tax Assets0000
Other Non-current Assets14K13K2.64M4.94M
Total Non-current Assets266K168K3.37M5.3M
Total Assets16.76M10.54M77.51M117.18M
Account Payables259K1.04M2.3M2.07M
Short-term Debt0000
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities53K45K896K2.91M
Total Current Liabilities595K1.38M4.93M10.55M
Long-term Debt0000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities43.92M43.91M126.78M0
Total Non-current Liabilities44.09M43.96M127.22M0
Total Liabilities44.68M45.34M132.15M10.55M
Common Stock0000
Retained Earnings(30.53M)(37.74M)(58.33M)(115.92M)
Accumulated OCI00081K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(27.92M)(34.8M)(54.64M)106.63M
Total Debt262K162K779K441K
Net Debt(15.3M)(9.57M)(60.86M)(46.61M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$62.4M
Short-term Investments$28.8M
Other Current$2.4M
Total Current Assets$93.6M
PP&E (Net)$269.0K
Other Non-current$4.7M
Total Non-current Assets$5.0M
Total Assets$98.6M

Analysis

Selected assets total $98.6M for Latest. The largest visible component is Cash & Equivalents at $62.4M, about 63.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 8, 2026
8-KCurrent reportOct 8, 2026
3Initial statement of beneficial ownershipOct 8, 2026
4Statement of changes in beneficial ownershipSep 11, 2026
4Statement of changes in beneficial ownershipAug 21, 2026

How much cash does AARD have?

Aardvark Therapeutics, Inc. Common Stock (AARD) reported $47.05M in cash and equivalents in fiscal 2025.

How much debt does AARD carry?

Aardvark Therapeutics, Inc. Common Stock (AARD) reported $441,000.00 of total debt, with net debt of -$46.61M.